Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study by Jørn Henrik Vold, Svetlana Skurtveit, Christer Aas, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

The association between psychological distress and alcohol consumption and physical activity: a population-based cohort study by Silvia Eiken Alpers, Silvia Eiken Alpers, Ståle Pallesen, Ståle Pallesen, Jørn Henrik Vold, Jørn Henrik Vold, Jørn Henrik Vold, Ellen Haug, Ellen Haug, Linn-Heidi Lunde, Linn-Heidi Lunde, Jens Christoffer Skogen, Jens Christoffer Skogen, Jens Christoffer Skogen, Asgeir Mamen, Silje Mæland, Lars Thore Fadnes, Lars Thore Fadnes

Get full text

Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020 by Jørn Henrik Vold, Fatemeh Chalabianloo, Christer F. Aas, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway by Jørn Henrik Vold, Else-Marie Løberg, Christer F. Aas, Jan Alexander Steier, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway by Mitra Bemanian, Ranadip Chowdhury, Krister Stokke, Christer Frode Aas, Kjell Arne Johansson, Jørn Henrik Vold, Lars Thore Fadnes

Get full text

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017 by Jørn Henrik Vold, Svetlana Skurtveit, Christer Aas, Fatemeh Chalabianloo, Pia Synnøve Kloster, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid a... by Jørn Henrik Vold, Anne Halmøy, Fatemeh Chalabianloo, Marianne Cook Pierron, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to... by Jørn Henrik Vold, Christer Aas, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Anne Halmøy, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020 by Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Eivind Meland, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group

Get full text

208:poster Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: an economic evaluation of the INTRO-HCV trial by Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes, Christer Frode Aas, Aaron G Lim, Ege Su Çağlar, Jørn-Henrik Vold

Changes in Body Mass Index and Their Associations with Psychological Distress, Worries, and Emotional Eating during the COVID-19 Pandemic: A Norwegian Cohort Study by Elaheh Javadi Arjmand, Jens Christoffer Skogen, Jørn Henrik Vold, Silvia Eiken Alpers, Erik Kristoffer Arnesen, Silje Mæland, Lars Thore Fadnes

Get full text

Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol fo... by Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Jan Tore Daltveit, Jørn Henrik Vold, Einar Furulund, Torgeir Gilje Lid, Lars Thore Fadnes

Get full text

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review by Jørn Henrik Vold, Christer Aas, Rafael Alexander Leiva, Peter Vickerman, Fatemeh Chalabianloo, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to... by Christer F. Aas, Jørn Henrik Vold, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Aaron G. Lim, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Emotional Eating and Changes in High-Sugar Food and Drink Consumption Linked to Psychological Distress and Worries: A Cohort Study from Norway by Elaheh Javadi Arjmand, Mitra Bemanian, Jørn Henrik Vold, Jens Christoffer Skogen, Gro Mjeldheim Sandal, Erik K. Arnesen, Silje Mæland, Lars Thore Fadnes

Get full text

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial by Jørn Henrik Vold, Fatemeh Chalabianloo, Else-Marie Løberg, Christer F. Aas, Aaron G. Lim, Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders by Christer F. Aas, Jørn Henrik Vold, Fatemeh Chalabianloo, Else-Marie Løberg, Aaron G. Lim, Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study by Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Tesfaye Madebo, Håvard Midgard, Olav Dalgard, Rafael Alexander Leiva, Lars T. Fadnes, for the INTRO-HCV Study Group

Get full text

Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway by Tesfaye Madebo, Mitra Bemanian, Jørn Henrik Vold, Ranadip Chowdhury, Christer Frode Aas, Karl Trygve Druckrey-Fiskaaen, Kjell Arne Johansson, Lars Thore Fadnes

Get full text

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 by Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Fatemeh Chalabianloo, Svetlana Skurtveit, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group

Get full text